• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ZIMMER BIOMET, INC. SHELL WITH CLUSTER HOLES POROUS 48 MM O.D.; PROSTHESIS, HIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ZIMMER BIOMET, INC. SHELL WITH CLUSTER HOLES POROUS 48 MM O.D.; PROSTHESIS, HIP Back to Search Results
Model Number N/A
Medical Device Problem Codes Unstable (1667); Malposition of Device (2616)
Health Effect - Clinical Code Joint Dislocation (2374)
Date of Event 09/11/2020
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4).Concomitant medical products: 00771100700-femoral stem 12/14 neck taper plasma sprayed press-fit cementless size 7.5 standard offset-64496778.00885100832-neutral liner 32 mm-63468929.00625006530-bone scr 6.5x30 self-tap-j6779178.00877503204- biolox⮠delta, ceramic femoral head, xl, 㸠32/+7, taper 12/14- 2993195.Multiple mdr reports were filed for this event, please see associated reports: 0001822565 - 2020 - 03728.0001822565 - 2020 - 03730.Customer has indicated that the product will not be returned to zimmer biomet for investigation, product location unknown.The investigation is in process.Once the investigation has been completed, a follow-up mdr will be submitted.
 
Event or Problem Description
It was reported patient underwent a left hip revision approximately 1-month post implantation due to subluxation, malposition, and instability.Attempts have been made and additional information on the reported event is unavailable at this time.
 
Event or Problem Description
No further event information available at the time of this report.
 
Additional Manufacturer Narrative
This follow-up report is being submitted to relay additional information.The following sections were updated/corrected.Updated: g4; h2; h3; h6.Reported event was confirmed via operative notes and x-rays reviewed by a healthcare professional.Review of the device history record for the shell identified no deviations or anomalies during manufacturing related to the reported event.A definitive root cause cannot be determined.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SHELL WITH CLUSTER HOLES POROUS 48 MM O.D.
Common Device Name
PROSTHESIS, HIP
Manufacturer (Section D)
ZIMMER BIOMET, INC.
56 e. bell drive
warsaw IN 46582
MDR Report Key10785759
Report Number0001822565-2020-03727
Device Sequence Number3644469
Product Code JDI
UDI-Device Identifier00889024151314
UDI-Public(01)00889024151314
Combination Product (Y/N)N
Initial Reporter StateCO
Initial Reporter CountryUS
PMA/510(K) Number
K200823
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2020
Device Explanted Year2020
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 01/07/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberN/A
Device Catalogue Number00875704801
Device Lot Number64530774
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Received by Manufacturer 10/16/2020
Supplement Date Received by Manufacturer01/06/2021
Initial Report FDA Received Date11/04/2020
Supplement Report FDA Received Date01/07/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
NI
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
SEE H10
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age50 YR
Patient Weight56
-
-